Most Recent
Car brand LDV denies ACCC’s case over off-road ad campaign
Chinese car brand LDV is fighting the consumer regulator's case alleging it misled customers about its vehicles, telling a court that ads showing the vehicles as durable in off-road terrains were not misleading. 
Construction PRO
Dexus claim for legal privilege over 7,500 docs faces contest by APAC
Dexus has claimed legal professional privilege prevents fellow owners of airport operator APAC from accessing tens of thousands of documents as they prepare for trial over an alleged breach of a shareholder deed.
Builder to get Full Court hearing over Keystone liquidator’s $158M freeze
The Full Federal Court will hear developer Robert Filippini’s appeal of freezing orders won by Keystone Asset Management's liquidators, as ASIC's investigation of Keystone's failed Shield fund ramps up.
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Mayne wins extension of FIRB deadline for Cosette takeover
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.
Construction PRO
John Holland wins row with Downer EDI over scope of construction dispute
John Holland has persuaded a court to limit an expert determination in a dispute with contractor Downer EDI over the construction of a rollingstock manufacturing facility in Torbanlea, Queensland.
Mayne, Cosette row to be decided on merits after panel resets merger clock
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Mayne wins breathing room in fight to get Cosette merger over the line
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
Construction PRO
Shangri-La director strictly liable in Victoria’s combustible cladding suit
The director of collapsed Shangri-La Construction is personally liable for the $3.2 million in costs of rectification work on external cladding at an apartment complex in southeast Melbourne, a judge has found.
Cosette appeals loss over exit from $672M Mayne Pharma merger
Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.